These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33685348)
1. Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets. Chen K; Gan JX; Huang ZP; Liu J; Liu HP Bioengineered; 2021 Dec; 12(1):875-885. PubMed ID: 33685348 [TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer. Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers. Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890 [TBL] [Abstract][Full Text] [Related]
4. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis. Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer. Li AH; Zhang HH Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994 [TBL] [Abstract][Full Text] [Related]
6. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles. Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822 [TBL] [Abstract][Full Text] [Related]
7. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets. Shu Q; Liu X; Yang J; Mou T; Xie F Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453 [TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis. Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis. Zhong P; Hua H; Chen S; Zhu Z; Xie F Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192 [TBL] [Abstract][Full Text] [Related]
11. MYC-Activated LncRNA Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway. Liu H; Han L; Liu Z; Gao N J Cell Physiol; 2019 Aug; 234(8):13843-13850. PubMed ID: 30618167 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. Liu X; Yang Q; Yan J; Zhang X; Zheng M J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic value of long noncoding RNA SNHG7 in cancers: a meta-analysis and bioinformatics. Wang J; Du S; Wang C; Zhu Z; Xie B; Zhang B Aging (Albany NY); 2021 Oct; 13(20):23796-23809. PubMed ID: 34714775 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis. Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis. Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A. Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302 [TBL] [Abstract][Full Text] [Related]
18. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA). Yan Z; Lu J; Xu X; You Y; Xu J; Xu T Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370. Cui X; Yu H; Yu T; Xiao D; Wang X Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]